REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -46.2% | 92,825 | -42.9% | 0.00% | – |
| Q4 2021 | $52,000 | -88.2% | 162,600 | -74.5% | 0.00% | – |
| Q3 2021 | $440,000 | -17.8% | 638,755 | -3.0% | 0.00% | – |
| Q2 2021 | $535,000 | +35.4% | 658,793 | +160.3% | 0.00% | – |
| Q1 2021 | $395,000 | +107.9% | 253,100 | +79.5% | 0.00% | – |
| Q4 2020 | $190,000 | +331.8% | 141,000 | +116.7% | 0.00% | – |
| Q2 2020 | $44,000 | +33.3% | 65,063 | -7.9% | 0.00% | – |
| Q1 2020 | $33,000 | +106.2% | 70,641 | +359.2% | 0.00% | – |
| Q1 2019 | $16,000 | – | 15,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 5,555,555 | $1,656,000 | 0.43% |
| NEA Management Company, LLC | 14,451,147 | $4,306,000 | 0.12% |
| Sarissa Capital Management LP | 1,851,851 | $552,000 | 0.05% |
| Ikarian Capital, LLC | 1,289,130 | $384,000 | 0.05% |
| FEDERATED HERMES, INC. | 29,048,265 | $8,656,000 | 0.02% |
| WealthTrust Axiom LLC | 68,000 | $20,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $4,000 | 0.00% |
| GYL FINANCIAL SYNERGIES, LLC | 34,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $37,000 | 0.00% |
| McGuire Investment Group, LLC | 15,000 | $4,000 | 0.00% |